Patents Represented by Attorney Lance K Ishimoto
  • Patent number: 7402730
    Abstract: Genetically engineered cells and animals are described that incorporate a mutated GHP1 allele. Animals that are homozygous for the mutated GHP1 allele are useful for the production of monoclonal antibodies against GHP1.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: July 22, 2008
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Mary Jean Sparks, Wenhu Huang
  • Patent number: 7374933
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in thereapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: May 20, 2008
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Jr.
  • Patent number: 7374932
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: May 20, 2008
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: D. Wade Walke, Erin Hilbun, Gregory Donoho, C. Alexander Turner, Jr., Gwenn Hansen, Hector BeltrandelRio, Isaac Van Sligtenhorst
  • Patent number: 7312079
    Abstract: Polynucleotide and polypeptide sequences that encode novel variant FAM3C proteins are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: December 25, 2007
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventor: Yi Hu